Manuel Grima Reyes

Senior Scientist at ONA Therapeutics

Manuel Grima Reyes has a varied work experience, beginning in 2015 as an Internship Student at the Vall d'Hebron Institute of Research (VHIR). Manuel then moved on to become a Master Thesis Student at VHIR in 2016. In 2018, they began working as an Early Stage Researcher at Inserm, and in 2019 they became a Metabolomics trainee at the Technion - Israel Institute of Technology. In 2021, they became a 4th year PhD fellow at the Société Française d'Hématologie, and they are currently working as a Junior Research Scientist at ONA Therapeutics.

Manuel Grima Reyes has a diverse educational background. From 2011 to 2016, they earned a Bachelor's degree in Biochemistry from Universitat Autònoma de Barcelona. From 2014 to 2015, they earned a Bachelor's degree in Biochemistry from Università degli Studi di Padova. From 2016 to 2017, they earned a Master's degree in Biomedicine from Universitat de Barcelona. Currently, they are pursuing a Doctor of Philosophy - PhD in Biological and Health Sciences from Université Côte d'Azur, which they are expected to complete in 2021. Additionally, they have obtained several certifications, including a French Certificate for Animal Laboratory Research from INSERM in 2018, a Spanish Certificate for Animal Laboratory Research from Universitat de Barcelona in 2017, and an Advanced Level Certificate in English from Escuela Oficial de Idiomas in 2014.

Location

Barcelona, Spain

Links


Org chart

No direct reports

Teams


Offices


ONA Therapeutics

Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism.


Industries

Headquarters

Barcelona, Spain

Employees

11-50

Links